Q1 2017 Holdings
Filed 2017-05-12 | 7 holdings | $816.1M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2017-05-22) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | Common | 00287Y109 | $711.5M | 10,917,258 | 87.2% |
| Biogen Inc(BIIB) | Common | 09062X103 | $103.0M | 376,788 | 12.6% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $619.3K | 11,106,211 | 0.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $437.0K | 7,470,528 | 0.1% |
| Theravance Biopharma Inc(TBPH) | Common | G8807B106 | $393.9K | 10,705,108 | 0.0% |
| Gilead Sciences Inc(GILD) | Common | 375558103 | $107.9K | 1,588,100 | 0.0% |
| Bioverativ Inc | Common | 09075E100 | $43.1K | 791,264 | 0.0% |